
Our understanding of - as well as our approach to - castration resistant prostate cancer is currently undergoing major changes. New drugs like the CYP-17 inhibitor abiraterone have shown that even in the "hormone refractory" stage the progression of prostate cancer is still driven by signaling of the androgen receptor. Changing the term to castration resistant prostate cancer is one consequence of these new insights. Here we give an overview on the current situation of drug development, therapeutic consequences and future trends.
Male, Androstenols, Clinical Trials as Topic, Neoplasms, Hormone-Dependent, Antineoplastic Agents, Hormonal, Prostatic Neoplasms, Steroid 17-alpha-Hydroxylase, Androgen Antagonists, Antineoplastic Agents, Bone Neoplasms, Docetaxel, Prostate-Specific Antigen, Cancer Vaccines, Ketoconazole, Drug Resistance, Neoplasm, Receptors, Androgen, Biomarkers, Tumor, Humans, Androstenes, Orchiectomy
Male, Androstenols, Clinical Trials as Topic, Neoplasms, Hormone-Dependent, Antineoplastic Agents, Hormonal, Prostatic Neoplasms, Steroid 17-alpha-Hydroxylase, Androgen Antagonists, Antineoplastic Agents, Bone Neoplasms, Docetaxel, Prostate-Specific Antigen, Cancer Vaccines, Ketoconazole, Drug Resistance, Neoplasm, Receptors, Androgen, Biomarkers, Tumor, Humans, Androstenes, Orchiectomy
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 4 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
